It’s called a misnomer because those terms describe a visible symptom, not the actual condition.
While alcohol consumption produces the most pronounced symptoms, acetaldehyde is generated from multiple sources beyond alcohol.
As a secondary detoxification pathway, the body relies on glutathione conjugation to support acetaldehyde clearance. However, this process can contribute to endogenous glutathione depletion, resulting in increased oxidative stress and potential downstream health impacts.
ALDH2 Deficiency is a genetically inherited metabolic condition that impairs the body’s ability to efficiently metabolize acetaldehyde, a toxic byproduct generated from alcohol consumption and normal metabolic processes.
Accumulation of acetaldehyde has been extensively studied and is associated with increased biological stress and potential long-term health risks.
Peer-reviewed studies have consistently shown that individuals with ALDH2 Deficiency who consume alcohol have a significantly increased risk of esophageal squamous cell carcinoma and certain upper aerodigestive tract cancers. This is largely attributed to prolonged exposure to acetaldehyde, which is classified as a Group 1 carcinogen.
When acetaldehyde accumulates, it can bind to proteins and DNA, forming adducts that disrupt normal cellular function. This process contributes to oxidative stress, mitochondrial dysfunction, and impaired cellular repair mechanisms.
Elevated acetaldehyde levels have been associated with inflammatory responses, vascular dysfunction, and increased cardiovascular stress, particularly in individuals who regularly consume alcohol.
